Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Henry

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|June 9, 2005
HIV-1 subtype diversity in MinnesotaTracy L Sides, Omobosola Akinsete, Keith Henry, et al.
AIDS Patient Care and Stds|September 10, 2016
Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement EffortsEva A Enns, Cavan S Reilly, Beth A Virnig, et al.
The Journal of Infectious Diseases|August 29, 2002
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategiesPablo Tebas, Keith Henry, Kristin Mondy, et al.
Biochemistry|May 8, 2002
Identification of a contact region between the tridecapeptide alpha-factor mating pheromone of Saccharomyces cerevisiae and its G protein-coupled receptor by photoaffinity labelingL Keith Henry, Sanjay Khare, Cagdas Son, et al.
AIDS Clinical Care|April 7, 2006
Roundtable. Who should be providing HIV care?Jonathan S Appelbaum, Richard Elion, Keith Henry, et al.
ACS Chemical Neuroscience|December 14, 2016
Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment ParadigmsDanielle Krout, Meghan Rodriquez, Stephen A Brose, et al.
AIDS (London, England)|December 29, 2004
C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056sKeith Henry, Douglas Kitch, Michael Dube, et al.
AIDS Research and Human Retroviruses|July 10, 2004
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infectionPablo Tebas, Kevin Yarasheski, Keith Henry, et al.
Proteins|August 16, 2008
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesKristian W Kaufmann, Eric S Dawson, L Keith Henry, et al.
The Journal of Biological Chemistry|December 3, 2013
The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transportBruce Felts, Akula Bala Pramod, Walter Sandtner, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|June 9, 2005
HIV-1 subtype diversity in MinnesotaTracy L Sides, Omobosola Akinsete, Keith Henry, et al.
AIDS Patient Care and Stds|September 10, 2016
Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement EffortsEva A Enns, Cavan S Reilly, Beth A Virnig, et al.
The Journal of Infectious Diseases|August 29, 2002
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategiesPablo Tebas, Keith Henry, Kristin Mondy, et al.
Biochemistry|May 8, 2002
Identification of a contact region between the tridecapeptide alpha-factor mating pheromone of Saccharomyces cerevisiae and its G protein-coupled receptor by photoaffinity labelingL Keith Henry, Sanjay Khare, Cagdas Son, et al.
AIDS Clinical Care|April 7, 2006
Roundtable. Who should be providing HIV care?Jonathan S Appelbaum, Richard Elion, Keith Henry, et al.
ACS Chemical Neuroscience|December 14, 2016
Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment ParadigmsDanielle Krout, Meghan Rodriquez, Stephen A Brose, et al.
AIDS (London, England)|December 29, 2004
C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056sKeith Henry, Douglas Kitch, Michael Dube, et al.
AIDS Research and Human Retroviruses|July 10, 2004
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infectionPablo Tebas, Kevin Yarasheski, Keith Henry, et al.
Proteins|August 16, 2008
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesKristian W Kaufmann, Eric S Dawson, L Keith Henry, et al.
The Journal of Biological Chemistry|December 3, 2013
The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transportBruce Felts, Akula Bala Pramod, Walter Sandtner, et al.
Pageof 14